58.48
-2.90 (-4.72%)
-2.90 (-4.72%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 6,633,903 |
|
|||||
| News | - | ||||||
| Day High | 61.79 | Low High |
|||||
| Day Low | 57.66 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| ARK Genomic Revolution ETF | ARKG | AMEX | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
 |
|
|---|---|---|---|---|
| -2.90 | -4.72% | 58.48 | 19:59:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 61.78 | 57.66 | 61.79 | 58.39 | 61.38 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 71,407 | 6,633,903 | 58.80 | 390,057,024 | - | 57.66 - 115.15 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 25,823 | 58.39 | USD |
Period:
Draw Mode:
ARK Genomic Revolution ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.09B | 87.00M | 87.00M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - | - |
News ARK Genomic Revolution ETF
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ARKG Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 64.49 | 66.23 | 57.66 | 62.37 | 4,611,543 | -6.01 | -9.32% |
| 1 Month | 78.49 | 79.5999 | 57.66 | 67.87 | 3,600,987 | -20.01 | -25.49% |
| 3 Months | 84.92 | 84.92 | 57.66 | 72.66 | 2,566,618 | -26.44 | -31.14% |
| 6 Months | 80.08 | 94.14 | 57.66 | 79.52 | 2,450,255 | -21.60 | -26.97% |
| 1 Year | 83.84 | 115.15 | 57.66 | 89.94 | 3,629,845 | -25.36 | -30.25% |
| 3 Years | 30.50 | 115.15 | 20.42 | 83.38 | 1,467,372 | 27.98 | 91.74% |
| 5 Years | 17.75 | 115.15 | 16.91 | 81.74 | 913,352 | 40.73 | 229.46% |
| The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
